Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®(2025-2034³â)
Blood Gas and Electrolyte Analyzers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1685167
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 130 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,882,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,585,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,849,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº 2024³â¿¡ 19¾ï ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, 2025³â¿¡¼­ 2034³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 5.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀåÀº ´ç´¢º´, È£Èí±â Áúȯ, ½ÅÀå Áúȯ, ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ç÷¾×°¡½º ¹× ÀüÇØÁú ¼öÄ¡¸¦ ÀÚÁÖ ¸ð´ÏÅ͸µÇØ¾ß ÇÏ´Â ¸¸¼º ÁúȯÀÇ Áõ°¡¿¡ ÈûÀÔ¾î ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ Áø´Ü °á°ú¸¦ º¸ÀåÇÏ¿© ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇØ ÀÌ·¯ÇÑ ºÐ¼®±â¸¦ Á¡Á¡ ´õ ¸¹ÀÌ Ã¤ÅÃÇϰí ÀÖ½À´Ï´Ù. º´¿ø, ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç(ICU)¿¡¼­ ½Ç½Ã°£ ÀÇ»ç °áÁ¤À» À§ÇØ ÀÌ·¯ÇÑ ±â±â¿¡ ÀÇÁ¸Çϸ鼭 ÇöÀå Áø´Ü(POC) ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â °Íµµ ½ÃÀå È®´ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

Blood Gas and Electrolyte Analyzers Market-IMG1

±â¼úÀÇ ¹ßÀüÀº Ç÷¾×°¡½º ¹× ÀüÇØÁú °Ë»ç ȯ°æÀ» º¯È­½ÃÄÑ Á¢±Ù¼º°ú È¿À²¼ºÀ» ³ô¿´½À´Ï´Ù. ÈÞ´ë¿ë ºÐ¼®±âÀÇ °³¹ß·Î ÀÇ·á Àü¹®°¡°¡ ȯÀÚÀÇ Ä§´ë ¿·¿¡¼­ °Ë»ç¸¦ ¼öÇàÇÒ ¼ö ÀÖ°Ô µÇ¾î Áø´Ü°ú Ä¡·áÀÇ Áö¿¬À» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È­¿Í ÀüÀÚ °Ç°­ ±â·Ï(EHR)°úÀÇ ÅëÇÕÀ¸·Î ¿öÅ©Ç÷ο찡 °£¼ÒÈ­µÇ¾î ¿À·ù°¡ ÁÙ¾îµé°í È¿À²¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. Áúº´ÀÇ Á¶±â ¹ß°ß°ú °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °­Á¶°¡ Áõ°¡Çϸ鼭 ÁßȯÀÚ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú Á¶±â °³ÀÔÀÌ °¡´ÉÇØÁ® ÀÌ·¯ÇÑ ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÇÔ²² ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ Áø´Ü µµ±¸ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ¾î Á¦Á¶¾÷ü¿Í ÀÌÇØ°ü°èÀڵ鿡°Ô ÀÌ ½ÃÀåÀº ¼öÀͼºÀÌ ³ôÀº ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 19¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 31¾ï ´Þ·¯
CAGR 5.2%

½ÃÀåÀº ÈÞ´ë¿ë ºÐ¼®±â¿Í º¥Ä¡Å¾ ºÐ¼®±â·Î ¼¼ºÐÈ­µÇ¸ç, ÈÞ´ë¿ë ±â±âÀÇ ¼ºÀåÀÌ µÎµå·¯Áú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÈÞ´ë¿ë ºÎ¹®Àº CAGR 5.4%·Î È®´ëµÇ¾úÀ¸¸ç 2034³â¿¡´Â 20¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.ÀÌ·¯ÇÑ ±ÞÁõÀº ÁַΠȯÀÚ °ü¸®¿¡ ÀÖ¾î ½Å¼ÓÇϰí Á¤È®ÇÑ °á°ú°¡ Áß¿äÇÑ ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç, ¿Ü·¡ Áø·á ½Ã¼³¿¡¼­ ÇöÀå °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ºÐ¼®±â´Â À̵¿¼º, »ç¿ë ÆíÀǼº, ºü¸¥ ó¸® ½Ã°£ µîÀÇ ÀÌÁ¡À» Á¦°øÇÏ¿© ÀÓ»óÀǰ¡ Áß¾Ó ÁýÁᫎ ½ÇÇè½Ç Å×½ºÆ® ¾øÀ̵µ ½Å¼ÓÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. Ȩ ÇコÄɾî¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ Áõ°¡ Ãß¼¼·Î ÀÎÇØ ÀÌ·¯ÇÑ ¼ÒÇü ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖÀ¸¸ç, ±âÁ¸ ÀÇ·á ȯ°æ ¹Û¿¡¼­µµ ½Ç½Ã°£ Áø´ÜÀÌ °¡´ÉÇØÁ³½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµÀÇ °üÁ¡¿¡¼­ ½ÃÀåÀº ÀÌ ½ÃÀåÀº ÇöÀå Áø·á Å×½ºÆ®, Áß¾Ó ½ÇÇè½Ç, Áø´Ü ¼¾ÅÍ, º´¿ø ¹× ±âŸ ÀÇ·á ½Ã¼³¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ÇöÀå Áø·á ºÎ¹®Àº ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ ºü¸£°í Á¤È®ÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ±ä±ÞÇÑ Çʿ伺¿¡ ÈûÀÔ¾î 2024³â ½ÃÀå Á¡À¯À²ÀÇ 35.5%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®±â´Â Áï°¢ÀûÀÎ °Ë»ç °á°ú°¡ »ý¸íÀ» ±¸ÇÒ ¼ö ÀÖ´Â ÀÀ±Þ½Ç, ¼ö¼ú½Ç, ÁßȯÀڽǿ¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ȯÀÚÀÇ º´»ó¿¡¼­ ½Ç½Ã°£ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â ºÐ¼®±â´Â ó¸® ½Ã°£À» Å©°Ô ´ÜÃàÇÏ¿© ¿öÅ©Ç÷οì È¿À²¼ºÀ» °³¼±Çϰí Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¿Ü·¡ Áø·á ¹× ÀçÅà ÀÇ·á ȯ°æ¿¡¼­ POC ºÐ¼®±âÀÇ »ç¿ëÀÌ È®´ëµÊ¿¡ µû¶ó ½ÃÀå¿¡¼­ÀÇ ÀÔÁö°¡ ´õ¿í °ø°íÇØÁö°í ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº 2024³â¿¡ 6¾ï 6,360¸¸ ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2034³â±îÁöÀÇ CAGR ¼ºÀå·üÀº 5%·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, È£Èí±â Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº Ç÷Áß °¡½º ¹× ÀüÇØÁú ¼öÄ¡¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇØ¾ß ÇϹǷΠ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ÀÇ Àα¸ °í·ÉÈ­·Î ÀÎÇØ ¸¸¼º ¹× ±Þ¼º °Ç°­ ¹®Á¦ÀÇ À§ÇèÀÌ ³ô¾ÆÁö¸é¼­ º´¿ø, Áø·á¼Ò, Ȩ ÇコÄɾî ȯ°æ¿¡¼­ ÀÌ·¯ÇÑ ºÐ¼®±âÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °¡Ä¡ ±â¹Ý Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ POC Å×½ºÆ® ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² ¹Ì±¹ ½ÃÀåÀÇ È®ÀåÀÌ ´õ¿í °¡¼ÓÈ­µÇ¾î ¾÷°è Ç÷¹À̾îÀÇ ÁÖ¿ä ¼öÀÍ Ã¢Ãâ¿øÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : µð¹ÙÀ̽º À¯Çüº°(2021-2034³â)

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°(2021-2034³â)

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2034³â)

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Blood Gas And Electrolyte Analyzers Market reached USD 1.9 billion in 2024 and is projected to expand at a CAGR of 5.2% between 2025 and 2034. This growth is fueled by the increasing prevalence of chronic conditions such as diabetes, respiratory disorders, kidney diseases, and cardiovascular ailments, all of which require frequent monitoring of blood gas and electrolyte levels. Healthcare providers are increasingly adopting these analyzers to ensure precise and timely diagnostic results, improving patient outcomes in critical care settings. The rising demand for point-of-care (POC) diagnostic solutions has also played a key role in market expansion, with hospitals, emergency departments, and intensive care units (ICUs) relying on these devices for real-time decision-making.

Blood Gas and Electrolyte Analyzers Market - IMG1

Advancements in technology have transformed the blood gas and electrolyte testing landscape, making it more accessible and efficient. The development of portable and handheld analyzers has allowed healthcare professionals to conduct tests at the patient's bedside, minimizing delays in diagnosis and treatment. Additionally, automation and integration with electronic health records (EHRs) have streamlined workflows, reducing errors and improving efficiency. The increasing emphasis on early disease detection and personalized medicine is further driving the demand for these analyzers, as they enable continuous monitoring and early intervention in critically ill patients. Moreover, the growing investments in healthcare infrastructure, coupled with an aging global population, are pushing the adoption of advanced diagnostic tools, making this market highly lucrative for manufacturers and stakeholders.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$ 1.9 Billion
Forecast Value$ 3.1 Billion
CAGR5.2%

The market is segmented into portable and benchtop analyzers, with portable devices expected to see substantial growth. The portable segment is projected to expand at a CAGR of 5.4%, reaching USD 2 billion by 2034. This surge is primarily driven by the rising demand for point-of-care testing, particularly in emergency rooms, ICUs, and ambulatory care facilities, where rapid and accurate results are critical for patient management. Portable analyzers offer the advantage of mobility, ease of use, and faster turnaround times, allowing clinicians to make prompt decisions without the need for centralized laboratory testing. The growing trend of home healthcare and remote patient monitoring is further increasing the demand for these compact devices, enabling real-time diagnostics outside traditional healthcare settings.

In terms of end-use, the market spans point-of-care testing, central laboratories, diagnostic centers, hospitals, and other healthcare facilities. The point-of-care segment accounted for 35.5% of the market share in 2024, driven by the urgent need for fast and precise diagnostic tools in critical care settings. These analyzers play a crucial role in emergency rooms, operating rooms, and ICUs, where immediate test results can be life-saving. Their ability to deliver real-time insights at the patient's bedside significantly reduces turnaround time, improving workflow efficiency and ensuring timely interventions. The expanding use of POC analyzers in ambulatory care and home healthcare settings is further solidifying their position in the market.

The U.S. blood gas and electrolyte analyzers market reached USD 663.6 million in 2024, with an anticipated growth rate of 5% CAGR from 2025 to 2034. The increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions is a major factor propelling market growth. These conditions require continuous monitoring of blood gas and electrolyte levels, driving demand for reliable and efficient diagnostic solutions. Additionally, the aging population in the U.S. faces a higher risk of both chronic and acute health issues, leading to greater adoption of these analyzers in hospitals, clinics, and home healthcare settings. The growing focus on value-based care, coupled with advancements in POC testing technologies, is expected to further accelerate the expansion of the U.S. market, making it a key revenue generator for industry players.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

Chapter 9 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â